Fate Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 11/14/2024 | 13.17 M | $46.09 M | 0.00% | 11.18% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 10.47 M | $36.66 M | 100.00% | 8.89% |
| VANGUARD GROUP INC | 11/13/2024 | 10.40 M | $36.41 M | -1.57% | 8.83% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 5.57 M | $19.50 M | 0.00% | 4.73% |
| STATE STREET CORP | 11/14/2024 | 5.25 M | $18.39 M | -1.61% | 4.46% |
| BOXER CAPITAL, LLC | 11/14/2024 | 4.96 M | $17.36 M | -39.62% | 4.21% |
| BELLEVUE GROUP AG | 11/14/2024 | 4.84 M | $16.94 M | 0.00% | 4.11% |
| CITADEL ADVISORS LLC | 11/14/2024 | 4.28 M | $14.99 M | -4.59% | 3.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 3.56 M | $12.45 M | 0.00% | 3.02% |
| JOHNSON & JOHNSON | 11/13/2024 | 3.38 M | $11.83 M | 0.00% | 2.87% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 3.38 M | $11.82 M | -17.17% | 2.87% |
| WOODLINE PARTNERS LP | 11/14/2024 | 3.07 M | $10.73 M | 205.96% | 2.60% |
| MORGAN STANLEY | 11/14/2024 | 3.06 M | $10.72 M | -2.69% | 2.60% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 3.00 M | $10.49 M | 0.00% | 2.55% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 2.82 M | $9.88 M | 20.22% | 2.40% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 2.62 M | $9.17 M | 22.94% | 2.22% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 2.43 M | $8.52 M | -5.46% | 2.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.26 M | $7.91 M | 0.48% | 1.92% |
| JPMORGAN CHASE & CO | 12/26/2024 | 1.84 M | $6.43 M | 18.21% | 1.56% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 1.69 M | $5.90 M | -15.75% | 1.43% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 1.68 M | $5.88 M | 24.00% | 1.43% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.60 M | $5.61 M | -20.25% | 1.36% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.59 M | $5.56 M | -6.28% | 1.35% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2024 | 1.47 M | $5.13 M | 194.94% | 1.25% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 975,000 | $3.41 M | 14.71% | 0.83% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 927,240 | $3.25 M | -39.14% | 0.79% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 870,000 | $3.05 M | 0.00% | 0.74% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 854,195 | $2.99 M | -56.98% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 763,808 | $2.67 M | -13.14% | 0.65% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 700,000 | $2.45 M | 0.00% | 0.59% |
| GCM GROSVENOR HOLDINGS, LLC | 11/14/2024 | 495,916 | $1.74 M | 0.00% | 0.42% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 459,565 | $1.61 M | -54.94% | 0.39% |
| BARCLAYS PLC | 11/19/2024 | 424,277 | $1.49 M | 245.26% | 0.36% |
| UBS GROUP AG | 11/14/2024 | 404,279 | $1.41 M | 145.98% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 362,619 | $1.27 M | -33.89% | 0.31% |
| E FUND MANAGEMENT CO., LTD. | 11/13/2024 | 353,771 | $1.24 M | -0.41% | 0.30% |
| BRUCE & CO., INC. | 11/14/2024 | 350,000 | $1.23 M | 16.67% | 0.30% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 345,575 | $1.21 M | 0.00% | 0.29% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 317,271 | $1.11 M | -2.08% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 299,286 | $1.05 M | -20.01% | 0.25% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 270,616 | $947,156 | -39.41% | 0.23% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 249,742 | $874,097 | 3.02% | 0.21% |
| FMR LLC | 11/13/2024 | 227,981 | $797,932 | 25.89% | 0.19% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 214,425 | $750,488 | -14.50% | 0.18% |
| HRT FINANCIAL LP | 11/12/2024 | 209,144 | $732,000 | 254.33% | 0.18% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 185,409 | $648,932 | 11.52% | 0.16% |
| CAXTON ASSOCIATES LP | 11/14/2024 | 167,957 | $587,850 | -2.84% | 0.14% |
| SWISS NATIONAL BANK | 11/07/2024 | 166,700 | $583,450 | -6.92% | 0.14% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 163,104 | $570,864 | -2.37% | 0.14% |
| RHUMBLINE ADVISERS | 11/12/2024 | 156,998 | $549,487 | -1.88% | 0.13% |
Fate Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 246 institutional investors and hedge funds held shares of Fate Therapeutics, Inc.. The most heavily invested institutionals were:
Redmile Group, LLC: 13.17 M
BlackRock Funding, Inc. /DE: 10.47 M
VANGUARD GROUP INC: 10.4 M
Deep Track Capital, LP: 5.57 M
STATE STREET CORP: 5.25 M
Boxer Capital, LLC: 4.96 M
97.34% of Fate Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 131.39 M shares in the last 24 months. This purchase volume represents approximately $211.54 M in transactions.